EXPLORE THE SCIENCE
Semaglutide Linked to 42% Fewer Psychiatric Hospital Episodes TL;DR: In Swedish registry data covering nearly 100,000 people with depression or anxiety, psychiatric hospital visits and sickness absence were 42% lower during semaglutide treatment periods — with…
Read article
The Brain That Won’t Shut Down: How Fragmented REM Sleep Breeds Depression TL;DR: Chronic insomnia fragments REM sleep through persistent hyperarousal, preventing emotional memory consolidation and creating a vicious cycle that breeds depression—but cognitive-…
Read article
Diabetes and Depression Are Not Just Comorbidities—They Drive Each Other TL;DR: Diabetes and depression form a vicious cycle: high blood sugar triggers neuroinflammation and HPA axis dysfunction that cause depression, while depression sabotages blood sugar con…
Read article
Transcranial direct current stimulation (tDCS) targeting the left dorsolateral prefrontal cortex (DLPFC) at 2-mA intensity effectively alleviates depressive symptoms and shows promise in reducing anxiety symptoms across various clinical conditions. Highlights:…
Read article
Women experiencing midlife stress-related exhaustion have a higher risk of developing dementia at a younger age and exhibit long-term cognitive impairments. Highlights: Higher Dementia Risk: Women with midlife stress-related exhaustion had a nearly threefold i…
Read article
The study demonstrated that selegiline (SEL) improves memory performance, reduces anxiety, and modulates oxidative stress in an Alzheimer’s disease (AD) rat model. Highlights: Memory Improvements: SEL administration improved recognition memory, spatial memory,…
Read article
Psychosocial factors such as stress and depression, along with physical health issues like tympanic abnormalities and diabetes, significantly contribute to dizziness and chronic dizziness in adults. Highlights: Prevalence & Chronicity: Dizziness affected 24.6%…
Read article
GLP-1 receptor agonists like semaglutide, used for managing Type 2 diabetes, may be linked to adverse mood changes, necessitating further investigation into their psychiatric effects. Highlights: GLP-1 Receptor Agonists: These medications mimic GLP-1 hormone e…
Read article
A study found that adults recovering from their first COVID-19 infection more than 1-year ago have higher levels of fatigue and other chronic neuropsychiatric symptoms, influenced by vaccination status and socioeconomic factors. Highlights: Adults who had thei…
Read article
TLDR: Patients with noise-induced hearing loss (NIHL) exhibit significant changes in the white matter (WM) microstructure of their brains, particularly affecting the auditory and language pathways. Highlights: A study compared 122 patients with varying degrees…
Read article